Zoetis Inc. (ZTS)

USD 167.01

(-2.21%)

Net Income Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual net income in 2023 was 2.34 Billion USD , up 10.88% from previous year.
  • Zoetis Inc.'s latest quarterly net income in 2024 Q3 was 682 Million USD , up 9.29% from previous quarter.
  • Zoetis Inc. reported an annual net income of 2.11 Billion USD in 2022, up 3.78% from previous year.
  • Zoetis Inc. reported an annual net income of 2.03 Billion USD in 2021, up 24.36% from previous year.
  • Zoetis Inc. reported a quarterly net income of 682 Million USD for 2024 Q3, up 9.29% from previous quarter.
  • Zoetis Inc. reported a quarterly net income of 624 Million USD for 2024 Q2, up 4.17% from previous quarter.

Annual Net Income Chart of Zoetis Inc. (2023 - 2009)

Historical Annual Net Income of Zoetis Inc. (2023 - 2009)

Year Net Income Net Income Growth
2023 2.34 Billion USD 10.88%
2022 2.11 Billion USD 3.78%
2021 2.03 Billion USD 24.36%
2020 1.63 Billion USD 9.2%
2019 1.5 Billion USD 5.04%
2018 1.42 Billion USD 65.28%
2017 864 Million USD 5.24%
2016 821 Million USD 142.18%
2015 339 Million USD -41.85%
2014 583 Million USD 15.67%
2013 504 Million USD 15.6%
2012 436 Million USD 77.96%
2011 245 Million USD 122.73%
2010 110 Million USD 210.0%
2009 -100 Million USD 0.0%

Peer Net Income Comparison of Zoetis Inc.

Name Net Income Net Income Difference
Amneal Pharmaceuticals, Inc. -83.99 Million USD 2890.709%
Bausch Health Companies Inc. -592 Million USD 495.946%
Catalent, Inc. -1.04 Billion USD 324.736%
Emergent BioSolutions Inc. -760.5 Million USD 408.218%
Elanco Animal Health Incorporated -1.23 Billion USD 290.414%
Perrigo Company plc -12.7 Million USD 18556.693%
Teva Pharmaceutical Industries Limited -559 Million USD 519.32%